Acute chest pain (ACP) is one of the most common symptoms encountered in emergency departments. It poses a significant diagnostic challenge due to its diverse etiology, ranging from benign conditions to life-threatening emergencies such as acute coronary syndrome (ACS).
Initial evaluation should include a thorough history and physical examination to identify high-risk features suggestive of ACS. The use of risk stratification tools, such as the HEART score, can aid in decision-making. Electrocardiogram (ECG) and cardiac biomarkers (troponin) are essential in the initial assessment.
Further diagnostic testing depends on the initial risk assessment. Low-risk patients may undergo stress testing or advanced imaging. High-risk patients should be considered for immediate invasive strategies. Coronary computed tomography angiography (CCTA) has emerged as a valuable tool in the evaluation of intermediate-risk patients.
Management strategies are guided by the underlying cause. ACS requires urgent revascularization, either by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Non-cardiac causes of ACP should be managed accordingly, with appropriate referral to specialists when necessary.
Disposition decisions should be individualized, based on the patient's risk profile, diagnostic evaluation, and response to initial management. High-risk patients warrant hospital admission, while selected low-risk patients may be safely discharged with close outpatient follow-up.
ACP represents a complex clinical scenario requiring a systematic approach to ensure appropriate diagnosis and management. Through a combination of clinical assessment, risk stratification, diagnostic testing, and tailored management strategies, healthcare professionals can effectively navigate the challenges posed by this common, yet potentially serious, clinical presentation.
1.
In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".
2.
Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.
3.
Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer
4.
CAR T cells improve patients' quality of life: a study
5.
Preoperative Embolization Linked to Relapse-Free Survival in Meningioma
1.
The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025
2.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
3.
Bone Marrow Niche Remodeling in Hematologic Dysfunction
4.
Public Health Strategies for Expanding Early Support Systems in Blood Disorders
5.
Clinical Pharmacology of Megakaryocyte Maturation-Targeted Therapeutics
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation